Heterogeneity of EGFR mutations in a patient treated with gefitinib as neo-adjuvant chemotherapy
Kosuke Mizoguchi(Senju Pharmaceutical (Japan)), Shigeru Kohno(Nagasaki University), Kohei Motoshima(Nagasaki University), Junya Fukuoka(University of Nagasaki), Shinnosuke Takemoto(Nagasaki University), Katsumi Nakatomi(Nagasaki University), Yoichi Nakamura(Nagasaki University), Minoru Fukuda(Nagasaki Prefectural Shimabara High School), Daiki Ogawara(Nagasaki University), Kuniko Abe(Japanese Red Cross Society, Japan)
Cited by 0
Related Papers
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study
|The Lancet Respiratory Medicine|2016|448
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections
|Clinical Infectious Diseases|1997|426
The Case for Adopting the “Species Complex” Nomenclature for the Etiologic Agents of Cryptococcosis
|mSphere|2017|413
Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment
|Nature Immunology|2007|175